Home > Healthcare > Medical Devices > Implantable Devices > Implantable Medical Devices Market

Implantable Medical Devices Market Share

Report ID: GMI4483
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Implantable Medical Devices Market Share

Some key players in the implantable medical devices market are

AbbVie Inc. (Allergan plc)
Zimmer Biomet
MicroPort Scientific Corporation
Henry Schein, Inc.
Smith & Nephew plc
Stryker Corporation
Medtronic
Abbott Laboratories, Inc.
Boston Scientific Corporation
Alcon Laboratories
Mindray Medical International Limited
Bausch & Lomb
POLYTECH Health & Aesthetics
Demant A/S
MED-EL GmbH
Advanced Bionics Corporation (Sonova Holdings AG)
W. L. Gore & Associates, Inc.
Cochlear Limited
Johnson & Johnson
BIOTRONIK SE & Co. KG.

These companies majorly engage in product innovation and customer base expansion tactics to stay ahead in the competitive landscape. For instance, in May 2022, Johnson & Johnson, a pharmaceutical firm, announced that its medical devices subsidiary, DePuy Synthes, received the U.S. FDA 510(k) clearance for INHANCE Shoulder Implant System. This allowed the company to efficiently enhance its market presence and obtain a competitive advantage.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for implantable medical devices was valued at more than USD 112.5 billion in 2022 and is set to progress at over 9% CAGR between 2023 and 2032 owing to advancements of disease management services for early diagnosis and disease detection.

The ambulatory surgical centers application segment accounted for over USD 19 billion in 2022 due to the mounting number of patients visiting ambulatory surgical centers for different interventional surgeries.

Static/non-active/passive segment is projected to depict more than 8% CAGR over 2023-2032 as a result of the low requirement for external power supply compared to its counterpart.

Europe implantable medical devices market valuation is foreseen to reach over USD 63.5 billion by 2032 on account of an upsurge in cardiovascular disorder instances and the increasing number of surgeries being performed resulting in extensive demand for pacemakers and implantable cardioverter defibrillators in the region.